HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Momoe Itsumi Selected Research

Momoe Itsumi Research Topics

Disease

11Prostatic Neoplasms (Prostate Cancer)
01/2020 - 05/2012
6Neoplasms (Cancer)
06/2014 - 01/2010
4Carcinogenesis
12/2015 - 05/2012
3Renal Cell Carcinoma (Grawitz Tumor)
03/2015 - 01/2010
2Hypoxia (Hypoxemia)
10/2021 - 09/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 05/2012
2Inflammation (Inflammations)
01/2017 - 01/2017
2Kidney Neoplasms (Kidney Cancer)
03/2015 - 03/2013
1Dental Caries (Decay, Dental)
07/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Hemangioendothelioma
10/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Glioma (Gliomas)
09/2012
1Liver Neoplasms (Liver Cancer)
08/2010
1Breast Neoplasms (Breast Cancer)
08/2010
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2009
1Escherichia coli Infections
11/2008

Drug/Important Bio-Agent (IBA)

7AndrogensIBA
07/2016 - 05/2012
6Androgen Receptors (Androgen Receptor)IBA
01/2020 - 06/2013
3enzalutamideIBA
07/2016 - 06/2014
3Phosphotransferases (Kinase)IBA
06/2014 - 08/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2012
2Messenger RNA (mRNA)IBA
10/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2018
2Glutathione (Reduced Glutathione)IBA
01/2017 - 01/2017
2Therapeutic UsesIBA
07/2016 - 08/2014
2SL0101IBA
06/2014 - 06/2014
1Immunoglobulin A (IgA)IBA
07/2022
1AntibodiesIBA
07/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1NADPH Oxidase 4IBA
10/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
10/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2021
1serotonin 5 receptorIBA
01/2020
1Serotonin ReceptorsIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2017
1EquolIBA
07/2016
1IsoflavonesIBA
07/2016
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
07/2016
16- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxalineIBA
12/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2015
1Biomarkers (Surrogate Marker)IBA
09/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2015
1CarcinogensIBA
03/2015
1phorbolIBA
08/2014
1Taxoids (Taxanes)IBA
06/2014
1taxaneIBA
06/2014
1Paclitaxel (Taxol)FDA LinkGeneric
06/2014
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
06/2014
1Small Interfering RNA (siRNA)IBA
06/2014
1Prostaglandin Receptors (Prostaglandin Receptor)IBA
06/2013
1human CBX5 proteinIBA
06/2013
1Protein Isoforms (Isoforms)IBA
06/2013
1Prostate-Specific Antigen (Semenogelase)IBA
06/2013
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2013
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2013
1Chromobox Protein Homolog 5IBA
06/2013
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2013
1InterferonsIBA
03/2013
1isocitric acid (isocitrate)IBA
09/2012
1alpha-hydroxyglutarateIBA
09/2012
1CollagenIBA
09/2012
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
05/2012
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2012
1Sunitinib (Sutent)FDA Link
05/2012
1tyrosine receptor (receptor, tyrosine)IBA
05/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2012
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
05/2012
1Platelet-Derived Growth FactorIBA
05/2012
1ErbB Receptors (EGF Receptor)IBA
05/2012
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2010
1Sorafenib (BAY 43-9006)FDA Link
08/2010
1TYK2 Kinase (Tyrosine Kinase 2)IBA
12/2009
1Myelin-Oligodendrocyte GlycoproteinIBA
12/2009
1Interleukin-17 (Interleukin 17)IBA
11/2008

Therapy/Procedure

10Castration
01/2020 - 05/2012
7Therapeutics
07/2016 - 05/2012
3Drug Therapy (Chemotherapy)
05/2012 - 01/2010
1Stem Cell Transplantation
03/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2015
1Radiotherapy
01/2010
1Immunotherapy
01/2010